From the Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
United States Naval Academy, Sport Psychology Services, Midshipmen Development Center, Annapolis, MD, USA.
Phys Sportsmed. 2021 Nov;49(4):445-449. doi: 10.1080/00913847.2020.1851158. Epub 2020 Dec 2.
: To determine rates of perioperative opioid use and characterize associations between preoperative depression and chronic and cumulative opioid consumption after ACL reconstruction.: Using insurance claims data, we identified 48,657 adults who underwent ACL reconstruction from 2010 to 2015, had prescription drug insurance, and had ≥1 year of continuous insurance enrollment postoperatively. Chronic opioid use was defined as filling ≥120 days' supply from 3 to 12 months postoperatively. Logistic and linear regression, controlled for age, sex, and Charlson Comorbidity Index value, were used to determine associations of preoperative depression with binary and continuous outcomes, respectively.: Preoperatively, 2,237 patients (4.6%) had depression and 2,387 (4.9%) were taking opioids; patients with depression had 6.5 times the odds (95% confidence interval [CI]: 5.8, 7.3) of taking opioids than patients without depression. Postoperatively, 25% of the patients filled ≥1 opioid prescription; mean duration of use was 13 ± 11 days, and 362 patients (0.7%) had chronic use. Patients with preoperative depression were less likely than patients without depression to fill an opioid prescription postoperatively (OR 0.2, 95% CI: 0.2, 0.2). Of patients who filled opioid prescriptions postoperatively, those with preoperative depression were more likely to refill that prescription at least once (OR 2.0, 95% CI: 1.9, 2.2) but did not have greater odds of chronic use (OR 0.9, 95% CI: 0.5, 1.5). Preoperative depression was not associated with greater cumulative opioid consumption from 3 to 12 months postoperatively (β = -40, 95% CI: -226, 146).: Although patients with preoperative depression were more likely to take opioids preoperatively and to obtain ≥1 opioid refill postoperatively, they did not have greater odds of chronic postoperative opioid use or greater cumulative opioid consumption after ACL reconstruction.
:为了确定围手术期阿片类药物使用的发生率,并描述术前抑郁与 ACL 重建后慢性和累积阿片类药物消耗之间的关系:我们使用保险索赔数据,确定了 2010 年至 2015 年间接受 ACL 重建的 48657 名成年人,他们有处方药物保险,并且术后有≥1 年的连续保险参保。慢性阿片类药物使用的定义是在术后 3 至 12 个月内服用≥120 天的供应量。使用逻辑和线性回归,控制年龄、性别和 Charlson 合并症指数值,分别确定术前抑郁与二元和连续结果的关联:术前,2237 名患者(4.6%)有抑郁,2387 名患者(4.9%)正在服用阿片类药物;与没有抑郁的患者相比,有抑郁的患者服用阿片类药物的可能性是其 6.5 倍(95%置信区间:5.8,7.3)。术后,25%的患者服用了≥1 份阿片类药物处方;平均使用时间为 13±11 天,有 362 名患者(0.7%)有慢性使用。与没有抑郁的患者相比,有术前抑郁的患者术后更不可能开阿片类药物处方(OR 0.2,95%CI:0.2,0.2)。对于术后服用阿片类药物处方的患者,有术前抑郁的患者再次开处方的可能性更高(OR 2.0,95%CI:1.9,2.2),但慢性使用的可能性没有增加(OR 0.9,95%CI:0.5,1.5)。术前抑郁与术后 3 至 12 个月内的累积阿片类药物消耗无相关性(β=-40,95%CI:-226,146)。:尽管术前抑郁的患者更有可能在术前服用阿片类药物,并在术后获得≥1 次阿片类药物补充,但他们在慢性术后阿片类药物使用或 ACL 重建后累积阿片类药物消耗方面没有更高的几率。